Transcriptomics Market Share

On the basis of geographical analysis, the global transcriptomics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific industry is likely to hold largest revenue share by 2036, on the back of rising healthcare expenditure across the region.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the rapidly developing biotech and diagnostic industry in the developed countries. For instance, in the U.S. around USD 100 billion were invested in biotech companies, in 2020. Moreover, the growing prevalence of rare cancers in the region is also estimated to boost the transcriptomics market growth. According to the data by the American Cancer Society, in the United States, about 60,650 new cases of leukemia were reported in 2021, with over 24,000 deaths caused from all kind of leukemia.